PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.44% | -45.82% | -35.93% | -47.34% | -44.79% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.35% | -50.79% | -54.17% | -28.81% | -26.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -79.06% | -46.11% | -37.29% | -46.49% | -44.07% |
|
|
|||||
| Total Current Assets | -79.06% | -46.11% | -37.29% | -46.49% | -44.07% |
| Net Property, Plant & Equipment | -22.12% | -20.93% | -19.89% | -18.95% | -18.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -76.37% | -63.74% | -- | -- | -- |
| Total Assets | -78.24% | -47.56% | -32.77% | -33.83% | -33.09% |
|
|
|||||
| Total Accounts Payable | 42.17% | 27.67% | 112.14% | 298.26% | 38.28% |
| Total Accrued Expenses | 9.93% | -55.78% | -73.88% | -53.02% | -23.89% |
| Short-term Debt | -- | -58.35% | -58.96% | -52.00% | -47.20% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8,289.60% | -47.99% | -40.75% | -26.13% | -11.13% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.34% | -44.45% | -44.50% | -27.32% | -26.43% |
|
|
|||||
| Total Current Liabilities | 7.34% | -44.45% | -44.50% | -27.32% | -26.43% |
| Long-Term Debt | -- | 66.96% | 27.47% | -1.19% | -6.27% |
| Short-term Debt | -- | -58.35% | -58.96% | -52.00% | -47.20% |
| Capital Leases | -76.94% | -63.66% | -58.48% | -56.89% | -55.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -49.47% | -15.79% | -19.40% | -17.07% | -17.11% |
|
|
|||||
| Common Stock & APIC | 6.54% | 6.99% | 12.30% | 11.39% | 11.14% |
| Retained Earnings | -16.83% | -17.50% | -18.94% | -20.03% | -22.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -122.43% | -82.59% | -51.32% | -57.03% | -48.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -122.43% | -82.59% | -51.32% | -57.03% | -48.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -122.43% | -82.59% | -51.32% | -57.03% | -48.38% |
|
|
|||||